1 July 2024 - July 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are a few major new/revised listings of note this month:

• Midostaurin (Rydapt) - new medicine
• Palbociclib (Ibrance) - restriction change
• Raxtozinameran '(Comirnaty Omicron (XBB.1.5) - new vaccine
• Ribociclib succinate (Kisqali) - new medicine

Read New Zealand Pharmaceutical Schedule update